Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: A nationwide, population-based study
- PMID: 33871388
- DOI: 10.1097/JCMA.0000000000000533
Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: A nationwide, population-based study
Abstract
Background: Central serous chorioretinopathy (CSCR) and liver cirrhosis share numerous risk factors and may have possible connections. We aimed to investigate whether patients with liver cirrhosis and the severity of cirrhosis have an increased incidence of CSCR.
Methods: This population-based retrospective cohort study was conducted by collecting data from the Taiwan National Health Insurance Research Database from January 1, 2000, to December 31, 2015. We included patients who were newly diagnosed with cirrhosis and selected an equal number of sex- and age-matched control subjects. The effect of cirrhosis on the risk of CSCR was examined via a Cox proportional hazard regression analysis. The cumulative incidence of CSCR was assessed with the Kaplan-Meier method and the log-rank test.
Results: Both groups in this study comprised a total of 25 925 individuals. The cirrhotic patients had a significantly higher cumulative risk of developing CSCR in following years than patients without cirrhosis (log-rank test < 0.001). Furthermore, compared with noncirrhotic patients, the risk of CSCR was increased 3.59-fold (95% confidence interval [CI], 2.31-5.28) in cirrhotic patients with complications, and 2.34-fold (95% CI, 1.27-3.24) in cirrhotic patients without complications. Additionally, male sex, springtime, diabetes mellitus, hepatitis B virus, and hepatitis C virus statistical significantly increased the incidence of CSCR.
Conclusion: Cirrhosis is an independent indicator of CSCR. Among the cirrhotic population, patients with ascites and other complications have a higher incidence of CSCR than those with uncomplicated cirrhosis. Physicians should be observant when managing cirrhotic patients with visual disturbances.
Copyright © 2021, the Chinese Medical Association.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
Similar articles
-
Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.Acta Ophthalmol. 2013 Nov;91(7):666-71. doi: 10.1111/j.1755-3768.2012.02528.x. Epub 2012 Sep 23. Acta Ophthalmol. 2013. PMID: 22998678
-
Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.Retina. 2014 Sep;34(9):1867-74. doi: 10.1097/IAE.0000000000000159. Retina. 2014. PMID: 24743638
-
Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.Br J Ophthalmol. 2014 Jan;98(1):110-4. doi: 10.1136/bjophthalmol-2013-303945. Epub 2013 Oct 29. Br J Ophthalmol. 2014. PMID: 24169652
-
Increased risk for central serous chorioretinopathy in nephrotic syndrome patients: A population-based cohort study.J Chin Med Assoc. 2021 Nov 1;84(11):1060-1069. doi: 10.1097/JCMA.0000000000000591. J Chin Med Assoc. 2021. PMID: 34320516
-
Central serous chorioretinopathy: a review of epidemiology and pathophysiology.Clin Exp Ophthalmol. 2013 Mar;41(2):201-14. doi: 10.1111/j.1442-9071.2012.02848.x. Epub 2012 Sep 21. Clin Exp Ophthalmol. 2013. PMID: 22788735 Review.
Cited by
-
Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification.Taiwan J Ophthalmol. 2022 Dec 5;12(4):381-393. doi: 10.4103/2211-5056.362601. eCollection 2022 Oct-Dec. Taiwan J Ophthalmol. 2022. PMID: 36660127 Free PMC article. Review.
References
-
- Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996; 103:2070–9.
-
- Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996; 121:26–34.
-
- Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013; 58:103–26.
-
- Chen SN, Chen YC, Lian I. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study. Br J Ophthalmol. 2014; 98:110–4.
-
- Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999; 128:63–8.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical